Stepan Inc. (SCL) Market Overview
- Price movement (last 24 h): +0.66 % to USD 63.97 (08:42 PM CET, Friday 23 Feb 2026).
- Trading volume (last 24 h): USD 6.9 mn.
- Shares outstanding: 22.7 mn.
- Market capitalization: USD 1.5 bn.
- 52‑week high: USD 68.00 (12 Feb 2026).
- 52‑week low: USD 41.82 (4 Nov 2025).
- Simple moving average (200 days): USD 56.41.
- Month‑to‑date change: –0.85 % since the end of January 2026.
Latest Financial Results – Third Quarter 2026
STEPAN CO released its Q3 2026 results on 30 Sep 2026. Key highlights include:
| Item | Q3 2026 | Q3 2025 | % Change |
|---|---|---|---|
| Revenue | Strong, consistent with prior periods | Strong | Stable |
| Operating Income | Lower than Q3 2025 | Higher | Decline |
| Net Profit | Lower than Q3 2025 | Higher | Decline |
| Earnings Before Tax | Modest decline | Higher | ↓ |
| Effective Tax Expense | Higher | Lower | ↑ |
| Capital Expenditures | Increased to support development | Stable | ↑ |
| Dividend Policy | Maintained | Maintained | – |
| Share‑Repurchase | Completed significant program | – | – |
| Balance Sheet | Solid liquidity, manageable debt | – | – |
- The company continued a substantial share‑repurchase program and maintained its dividend policy.
- Capital expenditures rose to support ongoing development and maintenance activities at major properties.
- The balance sheet remained solid with ample liquidity and manageable debt levels.
The overall outlook is stable but slightly subdued, with a focus on sustaining growth through investment and shareholder returns.
Related Stock Performance (Last 24 h)
| Ticker | Movement | Current Price (USD) | Market Cap (USD) | P/E Ratio |
|---|---|---|---|---|
| BRVE – Braveheart Bio | +3.8 % | 21.12 | 1.7 bn | – |
| PLAB – Photronics | –3.56 % | 28.17 | 1.7 bn | 10.23 |
| STBA – S & T Bancorp | +3.83 % | 50.75 | 1.7 bn | 13 |
| HOPE – Hope | +2.86 % | 14.09 | 1.7 bn | 13.42 |
| WHR – Whirlpool | +8.56 % | 28.20 | 1.7 bn | 9.06 |
S & T Bancorp (STBA) also reported its Q3 2026 earnings on 22 Oct 2026, showing a record increase in diluted EPS driven by higher net income and a share‑repurchase program that has bought back ~8 % of outstanding shares since late 2025. Core profitability metrics improved, and the bank’s regulatory capital ratios remained well above thresholds.
Company Profile
- Industry: Specialty and intermediate chemicals.
- Products: Surfactants, polymers, and specialty chemicals.
- Customers: Manufacturers in cleaning, paints, cosmetics, food & beverages, and other end‑product sectors.
- Stock Exchange: New York Stock Exchange (ticker SCL).
- Website: www.stepan.com
